Romedelin was originally shown to promote chromatin organization, nuclear architecture, and to decrease DNA damage markers in human lamin A/C-depleted cells and Hutchinson-Gilford Progeria Syndrome (HGPS)-derived patient cells [21]. Here, LMNA is linked to Hutchinson-Gilford progeria syndrome.